BTA-9881

CAS No. 1646857-24-0

BTA-9881( —— )

Catalog No. M34195 CAS No. 1646857-24-0

BTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 372 In Stock
10MG 635 In Stock
25MG 1387 In Stock
50MG 1841 In Stock
100MG 2483 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BTA-9881
  • Note
    Research use only, not for human use.
  • Brief Description
    BTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.
  • Description
    BTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    JAK/STAT Signaling
  • Target
    STAT
  • Recptor
    RSV
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1646857-24-0
  • Formula Weight
    390.82
  • Molecular Formula
    C21H15ClN4O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(=O)(N1[C@]2(C=3C(C(=O)N2CC1)=CC=NC3)C4=CC=C(Cl)C=C4)C=5C=CC=NC5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Pomstafib-2

    The pivaloyloxymethyl ester prodrug of Stafib-2, which is a potent, selective STAT5b inhibitor with Ki of 9 nM.

  • NSC 368262

    NSC 368262 is a selective STAT3 inhibitor that alkylates Cys468 in Stat3.

  • Stafib-1

    A potent, selective small molecule inhibitor of transcription factor STAT5b with Ki of 44 nM.